A detailed history of Voya Investment Management LLC transactions in Intellia Therapeutics, Inc. stock. As of the latest transaction made, Voya Investment Management LLC holds 31,042 shares of NTLA stock, worth $443,900. This represents 0.0% of its overall portfolio holdings.

Number of Shares
31,042
Previous 31,908 2.71%
Holding current value
$443,900
Previous $714,000 10.78%
% of portfolio
0.0%
Previous 0.0%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$19.72 - $27.36 $17,077 - $23,693
-866 Reduced 2.71%
31,042 $637,000
Q2 2024

Aug 14, 2024

SELL
$20.02 - $27.22 $983,642 - $1.34 Million
-49,133 Reduced 60.63%
31,908 $714,000
Q1 2024

May 15, 2024

SELL
$23.82 - $32.8 $325,833 - $448,671
-13,679 Reduced 14.44%
81,041 $2.23 Million
Q4 2023

Feb 14, 2024

BUY
$23.16 - $32.34 $884,017 - $1.23 Million
38,170 Added 67.5%
94,720 $2.89 Million
Q3 2023

Nov 14, 2023

BUY
$31.62 - $45.78 $686,248 - $993,563
21,703 Added 62.28%
56,550 $1.79 Million
Q2 2023

Aug 14, 2023

SELL
$34.58 - $46.03 $1.37 Million - $1.82 Million
-39,551 Reduced 53.16%
34,847 $1.42 Million
Q1 2023

May 15, 2023

SELL
$33.3 - $44.82 $1.25 Million - $1.69 Million
-37,678 Reduced 33.62%
74,398 $2.77 Million
Q4 2022

Feb 14, 2023

BUY
$33.21 - $62.69 $100,061 - $188,884
3,013 Added 2.76%
112,076 $3.91 Million
Q3 2022

Mar 03, 2023

SELL
$53.92 - $71.7 $162,460 - $216,032
-3,013 Reduced 2.69%
109,063 $6.1 Million
Q3 2022

Nov 14, 2022

BUY
$53.92 - $71.7 $2.09 Million - $2.78 Million
38,748 Added 55.11%
109,063 $6.1 Million
Q2 2022

Aug 15, 2022

SELL
$38.49 - $76.21 $4.39 Million - $8.69 Million
-114,058 Reduced 61.86%
70,315 $3.64 Million
Q1 2022

May 16, 2022

BUY
$58.27 - $118.99 $9.17 Million - $18.7 Million
157,452 Added 584.87%
184,373 $13.4 Million
Q4 2021

Feb 14, 2022

BUY
$100.76 - $138.36 $16,121 - $22,137
160 Added 0.6%
26,921 $3.18 Million
Q3 2021

Nov 15, 2021

BUY
$132.37 - $176.78 $219,998 - $293,808
1,662 Added 6.62%
26,761 $3.59 Million
Q2 2021

Aug 16, 2021

BUY
$60.88 - $161.91 $63,924 - $170,005
1,050 Added 4.37%
25,099 $4.06 Million
Q1 2021

May 17, 2021

BUY
$46.59 - $83.68 $93,086 - $167,192
1,998 Added 9.06%
24,049 $1.93 Million
Q4 2020

Feb 16, 2021

BUY
$18.83 - $63.53 $103,226 - $348,271
5,482 Added 33.09%
22,051 $1.2 Million
Q3 2020

Nov 16, 2020

BUY
$17.47 - $24.93 $22,693 - $32,384
1,299 Added 8.51%
16,569 $329,000
Q2 2020

Aug 14, 2020

SELL
$11.14 - $22.87 $46,743 - $95,962
-4,196 Reduced 21.56%
15,270 $321,000
Q1 2020

May 15, 2020

BUY
$9.44 - $15.58 $8,486 - $14,006
899 Added 4.84%
19,466 $238,000
Q4 2019

Feb 14, 2020

BUY
$10.43 - $17.67 $40,405 - $68,453
3,874 Added 26.37%
18,567 $272,000
Q2 2019

Aug 14, 2019

BUY
$13.88 - $18.41 $5,080 - $6,738
366 Added 2.55%
14,693 $241,000
Q4 2018

Feb 14, 2019

BUY
$11.39 - $27.13 $17,290 - $41,183
1,518 Added 11.85%
14,327 $196,000
Q2 2018

Aug 14, 2018

BUY
$20.02 - $30.79 $256,436 - $394,389
12,809 New
12,809 $350,000

Others Institutions Holding NTLA

About Intellia Therapeutics, Inc.


  • Ticker NTLA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,011,800
  • Market Cap $1.09B
  • Description
  • Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemoph...
More about NTLA
Track This Portfolio

Track Voya Investment Management LLC Portfolio

Follow Voya Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Voya Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Voya Investment Management LLC with notifications on news.